DnB Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

DnB Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Hold	1,146	–	–	﹤0.01%	908
2026 Q1	$369K	Buy	+1,146	New	+$355K	﹤0.01%	876

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DnB Asset Management's PRAX Position: Q2 2026 in Review

DnB Asset Management held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 1,146 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #908.

DnB Asset Management first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

DnB Asset Management held 1,146 shares of Praxis Precision Medicines worth $384K as of Q2 2026.
DnB Asset Management left its Praxis Precision Medicines share count unchanged in Q2 2026.
Praxis Precision Medicines made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #908 holding.
DnB Asset Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.